Teva to Acquire Allergan’s Generic Business

Teva Pharmaceuticals is buying Allergan’s generic drug business for $40.5 billion.

The Israeli pharmaceutical signed an agreement on 27 July for Allergan Generics and withdrew its plans to acquire Mylan’s business.

Under the new agreement, Teva will pay Allergan $33.75 billion in cash for the generics unit.

Full Story

This entry was posted in Pharmaceuticals. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s